Fatty liver disease affects millions, but what makes it turn dangerous? A new review of the science points to a surprising culprit: your immune system's own chatter.
The review looked at how different immune cells communicate in the liver. It found that the progression from simple fatty liver (MASLD) to the inflamed form (MASH) and even liver cancer is driven by crosstalk between macrophages, T cells, and B cells. These cells don't act alone; they talk to each other in ways that fuel inflammation and scarring.
This is early-stage research. The review didn't test any treatments or involve patients directly. It's a summary of what scientists know so far about the immune system's role. The authors suggest that targeting these immune conversations could lead to new therapies, but no specific drugs were evaluated.
For now, this helps explain why some people's fatty liver disease gets worse. It's a step toward understanding the disease, not a cure. If you're concerned about your liver health, talk to your doctor about what you can do today.
